The Japan Times
์ค๋ ์ฑํฅ
์ฌํ
Moderna and other groups get $60 million to develop Ebola vaccine
Richard Hatchett, head of CEPI, said that it was possible to get Ebola Bundibugyo (BDBV) vaccines ready for trials within a couple of months.
๐ฏ๐ต ์ผ๋ณธ ยท "BUNDIBUGYO" ยท ์ด 7๊ฑด
ํํฐ ๋ณด๊ธฐํ์ฌ ์ง์
50.0
0 = ๋ถ์ ์ฐ์ธ
50 = ์ค๋ฆฝ
100 = ๊ธ์ ์ฐ์ธ
์ต๊ทผ 7์ผ ๊ธฐ์ค 1,637๊ฑด์ ๋ถ์ํ ๊ฒฐ๊ณผ, ๋ด์ค ์ฌ๋ฆฌ์ง์๋ 50.0(๊ท ํ)์ ๋๋ค. ๊ธ์ 0๊ฑด(0.0%)ยท์ค๋ฆฝ 1,637๊ฑด(100.0%)ยท๋ถ์ 0๊ฑด(0.0%)์ด๋ฉฐ, ์ค๋ฆฝ ๋น์ค์ด ๋๋ ทํ๊ฒ ๋์ต๋๋ค. ์ฑํฅ ์ง์๋ ์ข ํฉ 0.0(์ค๋ ๊ท ํ)์ ๋๋ค.
Richard Hatchett, head of CEPI, said that it was possible to get Ebola Bundibugyo (BDBV) vaccines ready for trials within a couple of months.
The road into Bundibugyo winds through steep green mountains along Ugandaโs border with the Congo, where villages cling to hillsides and people have long moved easily between the two countries on foot.
Tedros said the rare Bundibugyo strain has no approved โ vaccines or treatments, making early palliative care โ including isolation, rehydration and pain management โ critical.
The outbreak is straining health systems in eastern Congo, where violence, displacement and distrust of authorities have hit efforts to contain the Bundibugyo strain's spread.
The entrance ban of residents from the Democratic Republic of the Congo, Uganda and South Sudan comes as the WHO raised the risk of โthe Bundibugyo strain to "very โ high."
The outbreak is caused by the rare Bundibugyo strain of the virus and has no approved vaccine or antibody treatment.
There are no vaccines or known drugs specifically approved to treat the rare Bundibugyo strain of Ebola in the Democratic Republic of Congo.